Trial Profile
Effect of Different Meal Types on the Pharmacokinetics of a Single 1 mg Oral Dose of UT-15C (Treprostinil Diethanolamine) Sustained Release Tablets in Healthy Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 15 Jun 2015
Price :
$35
*
At a glance
- Drugs Treprostinil (Primary)
- Indications Peripheral ischaemia; Pulmonary arterial hypertension; Systemic scleroderma
- Focus Adverse reactions; Pharmacokinetics
- Sponsors United Therapeutics Corporation
- 26 Jun 2014 New trial record
- 05 Mar 2010
- 05 Oct 2009